Sickle Cell Trait Linked to Chronic Kidney Disease Risk
By LabMedica International staff writers Posted on 30 Nov 2014 |
Sickle cell trait (SCT) is defined as inheritance of a single copy of the sickle mutation that results from a single base pair substitution in the gene encoding the β-globin chain of hemoglobin.
Although SCT largely has been considered a benign condition, renal manifestations are the most commonly reported complications and include impaired urinary concentration, asymptomatic hematuria, and papillary necrosis and it is estimated that SCT affects nearly 300 million people worldwide.
Scientists at Johns Hopkins University (Baltimore, MD, USA) and their colleagues from several other institutions used five large, prospective, US population-based studies to evaluate 15, 975 self-identified African Americans, 1,248 participants who were SCT carriers and 14,727 participants without SCT, the noncarriers. Genotype data for rs334 encoding the sickle cell mutation (HBB p.Glu7Val) were obtained by custom genotyping or exome sequencing, or by imputation into the remaining sample of African Americans with genome-wide genotyping.
Allele detection and genotype calling were performed using the ABI 7900HT and the Sequence Detection System software (Life Technologies, Grand Island, NY, USA; www.lifetechnologies.com). They examined kidney function outcomes by the number of risk alleles. Serum creatinine values were measured via a modified kinetic Jaffé method or isotope dilution mass spectrometry. Cystatin C was measured using the Siemens Healthcare Diagnostics BN II System (Malvern, PA, USA) by an immunonephelometric assay.
The team identified chronic kidney disease (CKD) among 2,233 participants and of these, 19.2% of cases occurred among individuals with SCT, while 13.5% of cases were among those without the condition. The rate of incident CKD was also higher among individuals with SCT than those without the condition, at 20.7% and 13.7%, respectively. The team also found that people with SCT had a faster decline in estimated glomerular filtration rate (eGFR), the rate at which fluid is filtered through the kidney; 22.6% of those with sickle cell trait experienced eGFR decline, compared with 19% of those without the condition. What is more, 31.8% of people with SCT experienced albuminuria, an excess of protein in the urine that can be a sign of a kidney disorder, compared with 19% of those free of SCT.
The authors concluded that in their large multicohort study, SCT was associated with CKD and incident CKD, decline in eGFR, and albuminuria in African Americans. Because screening for SCT is already being widely performed, accurate characterization of disease associations with SCT is critical to inform policy and treatment recommendations. These associations may offer an additional genetic explanation for the increased risk of CKD observed among African Americans, compared with other racial groups. The study was published on November 13, 2014, in the Journal of the American Medical Association.
Related Links:
Johns Hopkins University
Life Technologies
Siemens Healthcare Diagnostics
Although SCT largely has been considered a benign condition, renal manifestations are the most commonly reported complications and include impaired urinary concentration, asymptomatic hematuria, and papillary necrosis and it is estimated that SCT affects nearly 300 million people worldwide.
Scientists at Johns Hopkins University (Baltimore, MD, USA) and their colleagues from several other institutions used five large, prospective, US population-based studies to evaluate 15, 975 self-identified African Americans, 1,248 participants who were SCT carriers and 14,727 participants without SCT, the noncarriers. Genotype data for rs334 encoding the sickle cell mutation (HBB p.Glu7Val) were obtained by custom genotyping or exome sequencing, or by imputation into the remaining sample of African Americans with genome-wide genotyping.
Allele detection and genotype calling were performed using the ABI 7900HT and the Sequence Detection System software (Life Technologies, Grand Island, NY, USA; www.lifetechnologies.com). They examined kidney function outcomes by the number of risk alleles. Serum creatinine values were measured via a modified kinetic Jaffé method or isotope dilution mass spectrometry. Cystatin C was measured using the Siemens Healthcare Diagnostics BN II System (Malvern, PA, USA) by an immunonephelometric assay.
The team identified chronic kidney disease (CKD) among 2,233 participants and of these, 19.2% of cases occurred among individuals with SCT, while 13.5% of cases were among those without the condition. The rate of incident CKD was also higher among individuals with SCT than those without the condition, at 20.7% and 13.7%, respectively. The team also found that people with SCT had a faster decline in estimated glomerular filtration rate (eGFR), the rate at which fluid is filtered through the kidney; 22.6% of those with sickle cell trait experienced eGFR decline, compared with 19% of those without the condition. What is more, 31.8% of people with SCT experienced albuminuria, an excess of protein in the urine that can be a sign of a kidney disorder, compared with 19% of those free of SCT.
The authors concluded that in their large multicohort study, SCT was associated with CKD and incident CKD, decline in eGFR, and albuminuria in African Americans. Because screening for SCT is already being widely performed, accurate characterization of disease associations with SCT is critical to inform policy and treatment recommendations. These associations may offer an additional genetic explanation for the increased risk of CKD observed among African Americans, compared with other racial groups. The study was published on November 13, 2014, in the Journal of the American Medical Association.
Related Links:
Johns Hopkins University
Life Technologies
Siemens Healthcare Diagnostics
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines